Reata Pharmaceuticals, Inc. Stock Börse Stuttgart
Equities
2R3
US75615P1030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.63% | +373.53% |
2023 | Reata Pharmaceuticals, Inc. Announces Management Changes | CI |
2023 | Biogen Closes Reata Pharmaceuticals Acquisition | MT |
Latest transcript on Reata Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director of Finance/CFO | 60 | 23-09-25 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director/Board Member | - | 23-09-25 | |
Michael Dambach
BRD | Director/Board Member | - | 23-09-25 |
1st Jan change | Capi. | |
---|---|---|
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+2.21% | 22.57B | |
-10.88% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- RETA Stock
- 2R3 Stock